2015 HSC Section 1 Book of Articles

systematic strategy currently exists to identify toxicities of therapy for infants with IH. The consensus team agreed on a number of recommendations that arose froma reviewof existing evidence REFERENCES 1. HCUPnet. Healthcare Cost and Utilization Project. Agency for Healthcare Research and Quality. Available at: http://www. ahrq.gov/data/hcup. Accessed March 31, 2010 2. Haggstrom AN, Drolet BA, Baselga E, et al. Prospective study of infantile hemangio- mas: clinical characteristics predicting complications and treatment. Pediatrics . 2006;118(3):882 – 887 3. Frieden IJ, Drolet BA. Propranolol for in- fantile hemangiomas: promise, peril, pathogenesis. Pediatr Dermatol . 2009;26 (5):642 – 644 4. Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taïeb A. Propranolol for severe hemangiomas of infancy. N Engl J Med . 2008;358(24):2649 – 2651 5. Léauté-Labrèze C, Sans-Martin V. Héman- giome infantile [Infantile hemangioma]. Presse Med . 2010;39(4):499 – 510 6. Akhavan A, Zippin JH. Current treatments for infantile hemangiomas. J Drugs Der- matol . 2010;9(2):176 – 180 7. Baetz J, Eigelshoven S, Marquard J, Bruch-Gerharz D, Homey B, Meissner T. Infantiles Hämangiom. Erfolgreiche Behandlung mit Propranolo [Infantile hemangioma. Successful treatment with propranolol]. Hautarzt . 2010;61(4):290 – 292 8. Barrio VR, Drolet BA. Treatment of hemangiomas of infancy. Dermatol Ther . 2005;18(2):151 – 159 9. Boon LM, MacDonald DM, Mulliken JB. Complications of systemic corticosteroid therapy for problematic hemangioma. Plast Reconstr Surg . 1999;104(6):1616 – 1623 10. Boyce J, Dodge-Palomba S. Propranolol treatment in periocular pediatric patients with hemangiomas. Insight . 2010;35(1): 22 – 23 11. Buckmiller L, Dyamenahalli U, Richter GT. Propranolol for airway hemangiomas: case report of novel treatment. Laryngo- scope . 2009;119(10):2051 – 2054

supplemented by expert opinion and clinical experience (Table 6). These recommendations will provide the platform for large-scale phase II/III clinical trials to determine optimal

dosing regimens and long-term safety pro fi les. We anticipate that these guide- lines will be modi fi ed as more data are made available from these future studies.

hemangiomas in infancy]. Rev Med Liege . 2008;63(1):14 – 17 23. Jephson CG, Manunza F, Syed S, Mills NA, Harper J, Hartley BE. Successful treat- ment of isolated subglottic haemangioma with propranolol alone. Int J Pediatr Oto- rhinolaryngol . 2009;73(12):1821 – 1823 24. Li YC, McCahon E, Rowe NA, Martin PA, Wilcsek GA, Martin FJ. Successful treat- ment of infantile haemangiomas of the orbit with propranolol. Clin Experiment Ophthalmol . 2010;38(6):554 – 559 25. Löf fl er H, Kosel C, Cremer H, Kachel W. Die Propranolol-Therapie in der Behandlung problematischer Hämangiome: Eine neue Standardtherapie kündigt sich an [Pro- pranolol therapy to treat problematic hemangiomas : a new standard therapy makes its debut]. Hautarzt . 2009;60(12): 1013 – 1016 26. Fulkerson DH, Agim NG, Al-Shamy G, Metry DW, Izaddoost SA, Jea A. Emergent medical and surgical management of mediastinal infantile hemangioma with symptomatic spinal cord compression: case report and literature review. Childs Nerv Syst . 2010;26 (12):1799 – 1805 27. Manunza F, Syed S, Laguda B, et al. Propranolol for complicated infantile haemangiomas: a case series of 30 infants. Br J Dermatol . 2010;162(2):466 – 468 28. Marsciani A, Pericoli R, Alaggio R, Brisigotti M, Vergine G. Massive response of severe infantile hepatic hemangioma to prop- anolol. Pediatr Blood Cancer . 2010;54(1):176 29. Maturo S, Hartnick C. Initial experience using propranolol as the sole treatment for infantile airway hemangiomas. Int J Pediatr Otorhinolaryngol . 2010;74(3):323 – 325 30. Mistry N, Tzifa K. Use of propranolol to treat multicentric airway haemangioma. J Laryngol Otol . 2010;124(12):1329 – 1332 31. Mousa W, Kues K, Haas E, et al. Successful treatment of a large hemangioma with propranolol. J Dtsch Dermatol Ges . 2010;8 (3):184 – 186 32. Naouri M, Schill T, Maruani A, Bross F, Lor- ette G, Rossler J. Successful treatment of ulcerated haemangioma with propranolol. J

12. Buckmiller LM. Propranolol treatment for infantile hemangiomas. Curr Opin Otolar- yngol Head Neck Surg . 2009;17(6):458 – 459 13. Buckmiller LM, Munson PD, Dyamenahalli U, Dai Y, Richter GT. Propranolol for in- fantile hemangiomas: early experience at a tertiary vascular anomalies center. La- ryngoscope . 2010;120(4):676 – 681 14. Denoyelle F, Garabédian EN. Propranolol may become fi rst-line treatment in ob- structive subglottic infantile hemangio- mas. Otolaryngol Head Neck Surg . 2010; 142(3):463 – 464 15. Denoyelle F, Leboulanger N, Enjolras O, Harris R, Roger G, Garabedian EN. Role of Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma. Int J Pediatr Otorhinolaryngol . 2009;73(8): 1168 – 1172 16. Dickie B, Dasgupta R, Nair R, et al. Spec- trum of hepatic hemangiomas: manage- ment and outcome. J Pediatr Surg . 2009; 44(1):125 – 133 17. Draper H, Diamond IR, Temple M, John P, Ng V, Fecteau A. Multimodal management of endangering hepatic hemangioma: im- pact on transplant avoidance: a de- scriptive case series. J Pediatr Surg . 2008;43(1):120 – 125, discussion 126 18. Fay A, Nguyen J, Jakobiec FA, Meyer- Junghaenel L, Waner M. Propranolol for isolated orbital infantile hemangioma. Arch Ophthalmol . 2010;128(2):256 – 258 19. Hara K, Yoshida T, Kajiume T, Ohno N, Kawaguchi H, Kobayashi M. Successful treatment of Kasabach-Merritt syndrome with vincristine and diagnosis of the hemangioma using three-dimensional imaging. Pediatr Hematol Oncol . 2009;26 (5):375 – 380 20. Herrero Hernández A, Escobosa Sánchez O, Acha García T. Successful treatment with vincristine in PHACES syndrome. Clin Transl Oncol . 2007;9(4):262 – 263 21. Holmes WJ, Mishra A, Gorst C, Liew SH. Propranolol as fi rst-line treatment for in- fantile hemangiomas. Plast Reconstr Surg . 2010;125(1):420 – 421 22. Hoyoux C. La vincristine: nouveau traite- ment des hémangiomes infantiles? [Vin- cristine treatment for management of

PEDIATRICS Volume 131, Number 1, January 2013

229